Disagree
Home Deus Medical Deus Medical
FEMAMED 2.5
FEMAMED 2.5 - Deus Medical

FEMAMED 2.5 - Deus Medical

Brand:
Category:
Substance:
Dosage:
2.5 mg/tab
Package:
50 tablets
Price:
$38.00 - $62.00
See options
Product Overview

Letrozole introduced in 1997 as Femara by Novartis and has been authorized to be used for the treatment of breast cancer in women in menopause by reducing the levels of estrogen in the body. Letrozole is aromatase inhibitor and is a popular bodybuilding world, where it is used to reduce the estrogen-related effects of steroid use, such as water retention and gynecomastia.

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about FEMAMED 2.5 by Deus Medical, consult with your doctor or healthcare professional.

Products
Show more
Explore More Products
FAQ
When was Letrozole approved for medical use?
It was approved by the U.S. FDA in 1997 under the brand name Femara​.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

What is the primary medical application of Letrozole?
Is primarily used to address breast cancer in postmenopausal women.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Does Letrozole have off-label uses?
Yes, it is used off-label by bodybuilders to reduce estrogenic effects from steroid use​.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.